Driehaus Capital Management’s Edwards Lifesciences EW Stock Holding History

Driehaus Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,190	Closed	-$520K	–	493
2018 Q1	$520K	Buy	+11,190	New	+$486K	0.02%	397
2017 Q3	–	Sell	-34,539	Closed	-$1.36M	–	512
2017 Q2	$1.36M	Buy	34,539 +18,441	+115%	+$673K	0.05%	307
2017 Q1	$505K	Sell	16,098 -7,692	-32%	-$241K	0.02%	433
2016 Q4	$743K	Sell	23,790 -49,932	-68%	-$1.62M	0.03%	382
2016 Q3	$2.96M	Buy	73,722 +16,959	+30%	+$639K	0.1%	213
2016 Q2	$1.89M	Buy	56,763 +28,221	+99%	+$966K	0.07%	277
2016 Q1	$839K	Buy	+28,542	New	+$788K	0.03%	400

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Driehaus Capital Management's EW Position: Q2 2018 in Review

Driehaus Capital Management sold out of Edwards Lifesciences (EW) in Q2 2018, closing a stake of 11,190 shares — an estimated $520K sold.

Driehaus Capital Management first reported a position in EW in Q1 2016 and held it in 7 quarters. The position peaked at $2.96M in Q3 2016. 838 funds tracked by Wall St. Rank hold EW as of Q2 2018.

Driehaus Capital Management reported no remaining Edwards Lifesciences position as of Q2 2018 after selling out during the quarter.
Driehaus Capital Management sold 11,190 Edwards Lifesciences shares in Q2 2018, an estimated $520K.
Driehaus Capital Management first reported a position in Edwards Lifesciences in Q1 2016 and held it in 7 quarters.
Driehaus Capital Management's Edwards Lifesciences position peaked at $2.96M in Q3 2016.
838 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2018.

Based on Driehaus Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.